{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T17:28:59Z","timestamp":1758389339959,"version":"3.44.0"},"reference-count":27,"publisher":"BMJ","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart"],"accepted":{"date-parts":[[2001,6,27]]},"published-print":{"date-parts":[[2001,11,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>To assess the efficacy and safety of intravenous dofetilide in preventing induction of atrioventricular re-entrant tachycardia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>DESIGN<\/jats:title>\n                  <jats:p>A multicentre, open, dose ranging trial. Fifty one patients with electrically inducible atrioventricular re-entrant tachycardia were allocated to one of five doses of dofetilide (1.5, 3, 6, 9, and 15\u2009\u03bcg\/kg), two thirds of the dofetilide dose being given over a 15 minute loading period and the remainder over a 45 minute maintenance period.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN OUTCOME MEASURE<\/jats:title>\n                  <jats:p>Responders were defined as patients in whom dofetilide prevented reinduction of atrioventricular re-entrant tachycardia at the end of the infusion.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Intravenous dofetilide had no effect on tachycardia inducibility at the two lower doses (1.5 and 3\u2009\u03bcg\/kg) but prevented the reinduction of tachycardia at the three higher doses (6, 9, and 15\u2009\u03bcg\/kg) at a rate of 36% (11\/31). There was a clear relation between plasma dofetilide concentrations and efficacy (p\u2009=\u20090.009). In non-responders, dofetilide increased the cycle length of induced atrioventricular re-entrant tachycardia. Dofetilide increased the atrial and ventricular effective refractory periods, as well as the antegrade and retrograde effective refractory period of the accessory pathway. Treatment related side effects were reported in four patients, one with a new sustained incessant supraventricular tachycardia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Dofetilide shows promise as an agent for the prevention of atrioventricular re-entrant tachycardia in patients without structural heart disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heart.86.5.522","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T06:31:46Z","timestamp":1027751506000},"page":"522-526","source":"Crossref","is-referenced-by-count":6,"title":["Effects of intravenous dofetilide on induction of atrioventricular re-entrant tachycardia"],"prefix":"10.1136","volume":"86","author":[{"given":"S M","family":"Cobbe","sequence":"first","affiliation":[{"name":"aDepartment of Medical Cardiology, Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER, UK, \n\nbDepartment of Cardiology, The Freeman Hospital, Newcastle Upon Tyne, UK, \n\ncDivision of Cardiological Sciences, St George's Hospital Medical School, London SW17, UK, \n\ndCardiac Department, St Bartholomew's Hospital, London EC1, UK, \n\neRoyal Brompton National Heart and Lung Hospitals, London SW3, UK, \n\nfDepartment of Cardiology, Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark, \n\ngDepart"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R W F","family":"Campbell","sequence":"additional","affiliation":[{"name":"aDepartment of Medical Cardiology, Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER, UK, \n\nbDepartment of Cardiology, The Freeman Hospital, Newcastle Upon Tyne, UK, \n\ncDivision of Cardiological Sciences, St George's Hospital Medical School, London SW17, UK, \n\ndCardiac Department, St Bartholomew's Hospital, London EC1, UK, \n\neRoyal Brompton National Heart and Lung Hospitals, London SW3, UK, \n\nfDepartment of Cardiology, Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark, \n\ngDepart"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A J","family":"Camm","sequence":"additional","affiliation":[{"name":"aDepartment of Medical Cardiology, Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER, UK, \n\nbDepartment of Cardiology, The Freeman Hospital, Newcastle Upon Tyne, UK, \n\ncDivision of Cardiological Sciences, St George's Hospital Medical School, London SW17, UK, \n\ndCardiac Department, St Bartholomew's Hospital, London EC1, UK, \n\neRoyal Brompton National Heart and Lung Hospitals, London SW3, UK, \n\nfDepartment of Cardiology, Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark, \n\ngDepart"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A W","family":"Nathan","sequence":"additional","affiliation":[{"name":"aDepartment of Medical Cardiology, Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER, UK, \n\nbDepartment of Cardiology, The Freeman Hospital, Newcastle Upon Tyne, UK, \n\ncDivision of Cardiological Sciences, St George's Hospital Medical School, London SW17, UK, \n\ndCardiac Department, St Bartholomew's Hospital, London EC1, UK, \n\neRoyal Brompton National Heart and Lung Hospitals, London SW3, UK, \n\nfDepartment of Cardiology, Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark, \n\ngDepart"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Rowland","sequence":"additional","affiliation":[{"name":"aDepartment of Medical Cardiology, Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER, UK, \n\nbDepartment of Cardiology, The Freeman Hospital, Newcastle Upon Tyne, UK, \n\ncDivision of Cardiological Sciences, St George's Hospital Medical School, London SW17, UK, \n\ndCardiac Department, St Bartholomew's Hospital, London EC1, UK, \n\neRoyal Brompton National Heart and Lung Hospitals, London SW3, UK, \n\nfDepartment of Cardiology, Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark, \n\ngDepart"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P E","family":"Bloch-Thomsen","sequence":"additional","affiliation":[{"name":"aDepartment of Medical Cardiology, Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER, UK, \n\nbDepartment of Cardiology, The Freeman Hospital, Newcastle Upon Tyne, UK, \n\ncDivision of Cardiological Sciences, St George's Hospital Medical School, London SW17, UK, \n\ndCardiac Department, St Bartholomew's Hospital, London EC1, UK, \n\neRoyal Brompton National Heart and Lung Hospitals, London SW3, UK, \n\nfDepartment of Cardiology, Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark, \n\ngDepart"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"M\u00f8ller","sequence":"additional","affiliation":[{"name":"aDepartment of Medical Cardiology, Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER, UK, \n\nbDepartment of Cardiology, The Freeman Hospital, Newcastle Upon Tyne, UK, \n\ncDivision of Cardiological Sciences, St George's Hospital Medical School, London SW17, UK, \n\ndCardiac Department, St Bartholomew's Hospital, London EC1, UK, \n\neRoyal Brompton National Heart and Lung Hospitals, London SW3, UK, \n\nfDepartment of Cardiology, Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark, \n\ngDepart"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Jordaens","sequence":"additional","affiliation":[{"name":"aDepartment of Medical Cardiology, Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER, UK, \n\nbDepartment of Cardiology, The Freeman Hospital, Newcastle Upon Tyne, UK, \n\ncDivision of Cardiological Sciences, St George's Hospital Medical School, London SW17, UK, \n\ndCardiac Department, St Bartholomew's Hospital, London EC1, UK, \n\neRoyal Brompton National Heart and Lung Hospitals, London SW3, UK, \n\nfDepartment of Cardiology, Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark, \n\ngDepart"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2001,11,1]]},"reference":[{"key":"2025092004525406000_86.5.522.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199103213241201"},{"key":"2025092004525406000_86.5.522.2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0002-9149(91)90706-Q","article-title":"Efficacy and safety of intravenous sotalol for termination of paroxysmal supraventricular tachycardia.","volume":"68","author":"Jordaens","year":"1991","journal-title":"Am J Cardiol"},{"key":"2025092004525406000_86.5.522.3","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(95)90324-0"},{"key":"2025092004525406000_86.5.522.4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/BF00357041","article-title":"Efficacy of sotalol in controlling reentrant supraventricular tachycardias.","volume":"4","author":"Millar","year":"1990","journal-title":"Cardiovasc Drugs Ther"},{"key":"2025092004525406000_86.5.522.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)05281-1"},{"key":"2025092004525406000_86.5.522.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)80799-1"},{"key":"2025092004525406000_86.5.522.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00220-9"},{"key":"2025092004525406000_86.5.522.8","first-page":"S36","article-title":"Antiarrhythmic treatment of atrioventricular tachycardias.","volume":"17 (suppl 6)","author":"Goy","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"key":"2025092004525406000_86.5.522.9","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0022-3565(25)10827-6","article-title":"Voltage- and time-dependent block of the delayed K+ current in cardiac myocytes by dofetilide.","volume":"262","author":"Carmeliet","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"2025092004525406000_86.5.522.10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0022-3565(25)23172-X","article-title":"UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells.","volume":"256","author":"Gwilt","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"2025092004525406000_86.5.522.11","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1093\/oxfordjournals.eurheartj.a060790","article-title":"Effects of the new class III antiarrhythmic drug dofetilide on the atrial and ventricular intracardiac monophasic action potential in patients with angina pectoris.","volume":"16","author":"Sedgwick","year":"1995","journal-title":"Eur Heart J"},{"key":"2025092004525406000_86.5.522.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.1995.tb00445.x"},{"key":"2025092004525406000_86.5.522.13","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(92)90996-C"},{"key":"2025092004525406000_86.5.522.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00506-2"},{"key":"2025092004525406000_86.5.522.15","first-page":"661","article-title":"Conversion of AF and maintenance of sinus rhythm by dofetilide [abstract P3682].","volume":"19 (suppl)","author":"Greenbaum","year":"1998","journal-title":"Eur Heart J"},{"key":"2025092004525406000_86.5.522.16","first-page":"I-383","article-title":"Efficacy and safety of oral dofetilide in maintaining normal sinus in patients with atrial fibrillation\/flutter: a multicenter study [abstract 2145].","volume":"96 (suppl 8)","author":"Singh","year":"1997","journal-title":"Circulation"},{"key":"2025092004525406000_86.5.522.17","doi-asserted-by":"publisher","DOI":"10.1016\/0731-7085(91)80137-X"},{"key":"2025092004525406000_86.5.522.18","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.84.4.1831"},{"key":"2025092004525406000_86.5.522.19","doi-asserted-by":"crossref","first-page":"C27","DOI":"10.1093\/eurheartj\/18.suppl_C.27","article-title":"Using the right drug: a treatment algorithm for regular supraventricular tachycardias.","volume":"18","author":"L\u00e9vy","year":"1997","journal-title":"Eur Heart J"},{"key":"2025092004525406000_86.5.522.20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0002-9149(93)90958-F","article-title":"Role of alterations in refractoriness and conduction in the genesis of reentrant arrhythmias. Implications for antiarrhythmic effects of class III drugs.","volume":"72","author":"Wit","year":"1993","journal-title":"Am J Cardiol"},{"key":"2025092004525406000_86.5.522.21","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5273(95)02284-4"},{"key":"2025092004525406000_86.5.522.22","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(92)90247-V"},{"key":"2025092004525406000_86.5.522.23","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/oxfordjournals.eurheartj.a060402","article-title":"Atrial flutter can be terminated by a class III antiarrhythmic drug but not by a class IC drug.","volume":"15","author":"Crijns","year":"1994","journal-title":"Eur Heart J"},{"key":"2025092004525406000_86.5.522.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1991.tb02810.x"},{"key":"2025092004525406000_86.5.522.25","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00005344-199410000-00018","article-title":"Efficacy of ajmaline and propafenone in patients with accessory pathways: a prospective randomized study.","volume":"24","author":"Chen","year":"1994","journal-title":"J Cardiovasc Pharmacol"},{"key":"2025092004525406000_86.5.522.26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/eurheartj\/14.suppl_E.91","article-title":"Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.","volume":"14","author":"Manz","year":"1993","journal-title":"Eur Heart J"},{"key":"2025092004525406000_86.5.522.27","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(83)90010-8"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heart.86.5.522","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:53:03Z","timestamp":1758369183000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heart.86.5.522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11,1]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2001,11,1]]},"published-print":{"date-parts":[[2001,11,1]]}},"alternative-id":["10.1136\/heart.86.5.522"],"URL":"https:\/\/doi.org\/10.1136\/heart.86.5.522","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"type":"print","value":"1355-6037"},{"type":"electronic","value":"1468-201X"}],"subject":[],"published":{"date-parts":[[2001,11,1]]}}}